Literature DB >> 16987904

Visual function in human ocular toxoplasmosis.

Janine Scherrer1, Milko E Iliev, Markus Halberstadt, Laurent Kodjikian, Justus G Garweg.   

Abstract

AIM: To assess functional impairment in terms of visual acuity reduction and visual field defects in inactive ocular toxoplasmosis.
METHODS: 61 patients with known ocular toxoplasmosis in a quiescent state were included in this prospective, cross-sectional study. A complete ophthalmic examination, retinal photodocumentation and standard automated perimetry (Octopus perimeter, program G2) were performed. Visual acuity was classified on the basis of the World Health Organization definition of visual impairment and blindness: normal (> or =20/25), mild (20/25 to 20/60), moderate (20/60 to 20/400) and severe (<20/400). Visual field damage was correspondingly graded as mild (mean defect <4 dB), moderate (mean defect 4-12 dB) or severe (mean defect >12 dB).
RESULTS: 8 (13%) patients presented with bilateral ocular toxoplasmosis. Thus, a total of 69 eyes was evaluated. Visual field damage was encountered in 65 (94%) eyes, whereas only 28 (41%) eyes had reduced visual acuity, showing perimetric findings to be more sensitive in detecting chorioretinal damage (p<0.001). Correlation with the clinical localisation of chorioretinal scars was better for visual field (in 70% of the instances) than for visual acuity (33%). Moderate to severe functional impairment was registered in 65.2% for visual field, and in 27.5% for visual acuity.
CONCLUSION: In its quiescent stage, ocular toxoplasmosis was associated with permanent visual field defects in >94% of the eyes studied. Hence, standard automated perimetry may better reflect the functional damage encountered by ocular toxoplasmosis than visual acuity.

Entities:  

Mesh:

Year:  2006        PMID: 16987904      PMCID: PMC1857636          DOI: 10.1136/bjo.2006.100925

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  29 in total

1.  The visual field in toxoplasmic retinochoroiditis.

Authors:  M R Stanford; E A Tomlin; O Comyn; K Holland; C Pavesio
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Correlation between Octopus perimetry and fluorescein angiography after strontium-90 plaque brachytherapy for subfoveal exudative age related macular degeneration.

Authors:  A Jaakkola; E Vesti; I Immonen
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

3.  Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.

Authors:  Masoud Soheilian; Mohammad-Mehdi Sadoughi; Mehdi Ghajarnia; Mohammad H Dehghan; Shahin Yazdani; Hassan Behboudi; Arash Anisian; Gholam A Peyman
Journal:  Ophthalmology       Date:  2005-09-19       Impact factor: 12.079

4.  Ocular toxoplasmosis and visual field defects.

Authors:  W G Martin; G C Brown; R K Parrish; R Kimball; M A Naidoff; W E Benson
Journal:  Am J Ophthalmol       Date:  1980-07       Impact factor: 5.258

5.  Ocular toxoplasmosis: clinical features and prognosis of 154 patients.

Authors:  Lotje E H Bosch-Driessen; Tos T J M Berendschot; Jenny V Ongkosuwito; Aniki Rothova
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

6.  Toxoplasmic chorioretinitis affecting the macula.

Authors:  M Saari
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-06

7.  Presumed toxoplasmosic anterior optic neuropathy.

Authors:  James T Banta; Janet L Davis; Byron L Lam
Journal:  Ocul Immunol Inflamm       Date:  2002-09       Impact factor: 3.070

8.  An update on current practices in the management of ocular toxoplasmosis.

Authors:  Gary N Holland; Kevan G Lewis
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

9.  [Retinochoroiditis as a diagnostic indication of acute systemic toxoplasmosis in an immunocompetent patient].

Authors:  H Wenkel; U Schönherr
Journal:  Klin Monbl Augenheilkd       Date:  1995-11       Impact factor: 0.700

10.  Functional visual effects of lesions located near the optic nerve head.

Authors:  J M Enoch; E A Essock; R A Williams; M Barricks
Journal:  Doc Ophthalmol       Date:  1985-11-15       Impact factor: 2.379

View more
  7 in total

1.  Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia.

Authors:  D Kovačević-Pavićević; A Radosavljević; A Ilić; I Kovačević; O Djurković-Djaković
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

2.  Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Authors:  Farzan Kianersi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Int Ophthalmol       Date:  2012-06-26       Impact factor: 2.031

3.  Ocular toxoplasmosis in Iran: 40 cases analysis.

Authors:  Seidali Tabatabaei; Mohammad Soleimani; Alireza Foroutan; Mehdinili Ahmadabadi; Reza Zarei; Nilofar Piri; Arzhang Gordiz
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

4.  [Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists].

Authors:  N Torun; Z Sherif; J Garweg; U Pleyer
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

5.  Case of Macular Hole Secondary to Ocular Toxoplasmosis Treated Successfully by Vitrectomy with Inverted Internal Limiting Membrane Flap.

Authors:  Mizuki Ikeda; Takayuki Baba; Yuri Aikawa; Jiro Yotsukura; Hirotaka Yokouchi; Shuichi Yamamoto
Journal:  Case Rep Ophthalmol       Date:  2021-05-10

6.  High frequency of ocular toxoplasmosis in Quindío, Colombia and risk factors related to the infection.

Authors:  Jorge Enrique Gómez-Marín; Juliana Muñoz-Ortiz; Manuela Mejía-Oquendo; José Y Arteaga-Rivera; Nicolás Rivera-Valdivia; María Cristina Bohórquez-Granados; Stefany Velasco-Velásquez; Gabriela Castaño-de-la-Torre; John Alejandro Acosta-Dávila; Laura Lorena García-López; Elizabeth Torres-Morales; Mónica Vargas; Juan David Valencia; Daniel Celis-Giraldo; Alejandra de-la-Torre
Journal:  Heliyon       Date:  2021-04-05

7.  An Open-source Static Threshold Perimetry Test Using Remote Eye-tracking (Eyecatcher): Description, Validation, and Preliminary Normative Data.

Authors:  Pete R Jones
Journal:  Transl Vis Sci Technol       Date:  2020-07-13       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.